期刊
ONCOLOGY REPORTS
卷 41, 期 5, 页码 2937-2944出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/or.2019.7072
关键词
Timosaponin A-III; apoptosis; autophagy; T-cell acute lymphoblastic leukemia; mechanism
类别
资金
- Shandong Province medical science and technology development project [2016WS0701]
- Science and Technology Benefiting Project of Qingdao City [15-9-2-83-nsh]
- Science and Technology Project of Yantai [2016WS003]
- Scientific researching fund projects of Yantai Yu Huang Ding Hospital [201504]
Timosaponin A-III (TAIII) is a saponin isolated from anemarrhena asphodeloides and possesses the inhibitory effect on proliferation of multiple tumor cells. In the present study, the antitumor effect of TAIII and its underlying molecular mechanisms were investigated in vitro in T-cell acute lymphoblastic leukemia (T-ALL) Jurkat cells. The results demonstrated that TAIII inhibits the viability of Jurkat cells in a time- and dose-dependent manner, and induces apoptosis of Jurkat cells in a dose-dependent manner. Transmission electron microscopy demonstrated the formation of numerous autophagosomes in TAIII-treated Jurkat cells. Furthermore, monodansylcadaverine (MDC)-labeled autophagic vacuoles were observed following TAIII treatment by an inverted fluorescence microscope and MDC accumulation increased notably in TAIII treatment groups in a concentration-dependent manner. B-cell lymphoma-2 (Bcl-2)-associated X (Bax) was upregulated while Bcl-2 was reduced following TAIII treatment, indicating that the pro-apoptotic mechanism of TAIII may be associated with upregulation of Bax. Further investigation revealed that TAIII promotes the expression of autophagy-associated proteins Beclin 1 and LC3-II, and inhibits the phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin kinase pathway. The present study revealed that the antitumor activity of TAIII was primarily achieved by the induction of cell apoptosis and autophagy, indicating a promising potential as a novel effective reagent against T-ALL.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据